Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 7.40
+0.40 (5.71%)
Mar 6, 2026, 11:50 AM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 30.34 million as of March 6, 2026. Its market cap has increased by 5.02% in one year.
Market Cap
30.34M
Enterprise Value
29.45M
Revenue
8.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.40
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 30.34M, a decrease of -69.95%. That is a compound annual growth rate of -20.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 30.34M | 9.38% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 234.01B |
| GSK plc | 84.79B |
| Haleon | 34.64B |
| Smith & Nephew | 11.35B |
| ImmuPharma | 34.94M |
| Provexis | 31.08M |
| Palatin Technologies | 30.13M |
| Poolbeg Pharma | 28.91M |